Medical Xpress news

Medical Xpress / From bench to bedside—research in mice leads to answers for undiagnosed human neurodevelopmental conditions

Nearly 30 years ago, researchers began studying the gene Astn1, which encodes the cell adhesion protein astrotactin 1 in mice, and its role in brain development. During this time, they learned a great deal about the function ...

Feb 10, 2026 in Genetics
Medical Xpress / How chronic inflammation traps white blood cells in hybrid states and blocks healing

Researchers at the University of North Carolina at Chapel Hill have uncovered how chronic inflammation disrupts the immune system's ability to heal the body, offering new insight into diseases associated with inflammation ...

Feb 10, 2026 in Inflammatory disorders
Medical Xpress / 3D-printed brain models could improve medical research and training

University of Missouri researchers are developing new ways to better simulate the complex nature of human brain tissue. For years, scientists have worked to uncover how the brain responds to mechanical forces and electromagnetic ...

Feb 10, 2026 in Biomedical technology
Medical Xpress / New study finds near-universal fentanyl exposure with xylazine in some—but not all—US cities

In the national conversation about overdose, fentanyl is often framed as a single, wide-reaching crisis, but new evidence from five major U.S. cities suggests a more fragmented, complex reality. In an article published in ...

Feb 10, 2026 in Addiction
Medical Xpress / Gamma-synced brain stimulation can nudge people to behave less selfishly

Stimulating two brain areas, nudging them to collectively fire in the same way, increases a person's ability to behave altruistically, according to a study published in the PLOS Biology by Jie Hu from East China Normal University ...

Feb 10, 2026 in Psychology & Psychiatry
Medical Xpress / Tiny one- to three-base RNAs could help stop autoimmune inflammation, study suggests

RNA-based medicine is about to take a huge leap forward thanks to the discovery of extremely short RNA fragments with important anti-inflammatory properties. Professor Michael Gantier's latest research, published in Nature ...

Feb 10, 2026 in Immunology
Medical Xpress / Combination treatment may slow disease progression in advanced sarcoma

An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. "These findings support ...

Feb 10, 2026 in Oncology & Cancer
Medical Xpress / In comparing real-world costs and benefits of fibromyalgia medications, a clear winner emerges

Fibromyalgia is a long-term chronic condition that causes widespread pain in the muscles and soft tissues throughout the body. The illness can affect people of all ages and has a major impact on quality of life, often making ...

Feb 10, 2026 in Medications
Medical Xpress / Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies

Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, explain why patients respond ...

Feb 10, 2026 in Oncology & Cancer
Medical Xpress / Ovarian cancer cells surprise scientists—the body's own defense may be the key to longer survival

A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to stronger immune responses ...

Feb 10, 2026 in Oncology & Cancer
Medical Xpress / Genetic link between type 2 diabetes and high blood pressure uncovered

Type 2 diabetes and high blood pressure share a genetic link, according to new research from the University of Surrey, U.K., and the Université de Lille, France. In a large-scale study, scientists examined genetic data linked ...

Feb 10, 2026 in Cardiology
Medical Xpress / 'Stiff' cells provide new explanation for differing symptoms in sickle cell patients

A new breakthrough study led by researchers at the University of Minnesota Twin Cities could explain why patients with the same genetic sickle cell mutation experience different levels of pain, organ damage, and response ...